Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Opinion in Investigational Drugs (London, England : 2000)|November 19, 2003
SLV-308. SolvayWilliam A WolfPsychopharmacology|August 20, 2002
Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted ratLaurence Mignon, William A WolfPsychopharmacology|February 1, 2007
Postsynaptic 5-HT1A receptor stimulation increases motor activity in the 6-hydroxydopamine-lesioned rat: implications for treating Parkinson's diseaseLaurence Mignon, William A WolfNeuroreport|April 29, 2005
8-hydroxy-2-(di-n-propylamino)tetralin reduces striatal glutamate in an animal model of Parkinson's diseaseLaurence J Mignon, William A WolfPsychopharmacology|June 30, 2005
Enhanced 5-HT2C receptor signaling is associated with haloperidol-induced "early onset" vacuous chewing in rats: implications for antipsychotic drug therapyWilliam A Wolf, Gerald J Bieganski, Veronica Guillen, et al.Plos One|September 18, 2014
Evidence for fibroblast growth factor-2 as a mediator of amphetamine-enhanced motor improvement following strokeWilliam A Wolf, Jody L Martin, Gwendolyn L Kartje, et al.Brain Research|June 1, 2010
Long-term motor improvement after stroke is enhanced by short-term treatment with the alpha-2 antagonist, atipamezoleErik J Beltran, Catherine M Papadopoulos, Shih-Yen Tsai, et al.Stroke|November 29, 2008
Motor recovery and axonal plasticity with short-term amphetamine after strokeCatherine M Papadopoulos, Shih-Yen Tsai, Veronica Guillen, et al.Pageof 1